News headlines about INC Research Holdings (NASDAQ:INCR) have trended somewhat positive this week, Accern Sentiment reports. Accern ranks the sentiment of media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. INC Research Holdings earned a news sentiment score of 0.23 on Accern’s scale. Accern also gave media coverage about the company an impact score of 45.8125432810255 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

These are some of the news headlines that may have impacted Accern’s analysis:

Shares of INC Research Holdings (INCR) traded down 0.18% during mid-day trading on Friday, reaching $54.80. 432,327 shares of the company’s stock traded hands. The firm has a market capitalization of $2.97 billion, a price-to-earnings ratio of 33.58 and a beta of 1.42. The stock has a 50-day moving average price of $56.86 and a 200 day moving average price of $51.93. INC Research Holdings has a 12-month low of $40.65 and a 12-month high of $61.10.

INC Research Holdings (NASDAQ:INCR) last issued its earnings results on Thursday, July 27th. The company reported $0.64 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.64. The business had revenue of $258.10 million for the quarter, compared to the consensus estimate of $256.76 million. INC Research Holdings had a net margin of 5.69% and a return on equity of 40.69%. The company’s revenue for the quarter was down .3% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.61 EPS. Analysts anticipate that INC Research Holdings will post $2.60 EPS for the current fiscal year.

INCR has been the topic of several recent analyst reports. Robert W. Baird raised INC Research Holdings from a “neutral” rating to an “outperform” rating and raised their target price for the stock from $46.00 to $66.00 in a research note on Thursday, May 11th. TheStreet raised INC Research Holdings from a “c” rating to a “b-” rating in a research note on Monday, April 17th. William Blair cut INC Research Holdings from an “outperform” rating to a “market perform” rating in a research note on Tuesday, June 20th. Goldman Sachs Group, Inc. (The) reissued a “buy” rating and issued a $65.00 target price on shares of INC Research Holdings in a research note on Monday, August 7th. Finally, KeyCorp raised INC Research Holdings from a “sector weight” rating to an “overweight” rating and set a $68.00 target price on the stock in a research note on Monday, June 5th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and five have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $63.79.

ILLEGAL ACTIVITY NOTICE: “INC Research Holdings (INCR) Earning Somewhat Favorable Press Coverage, Report Shows” was published by Watch List News and is owned by of Watch List News. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark law. The correct version of this news story can be viewed at

In other INC Research Holdings news, CEO Alistair Macdonald sold 10,555 shares of the company’s stock in a transaction dated Monday, July 3rd. The shares were sold at an average price of $58.38, for a total value of $616,200.90. Following the transaction, the chief executive officer now directly owns 83,935 shares in the company, valued at approximately $4,900,125.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Christopher L. Gaenzle sold 6,873 shares of the company’s stock in a transaction dated Friday, June 30th. The stock was sold at an average price of $58.32, for a total transaction of $400,833.36. Following the completion of the transaction, the chief accounting officer now owns 47,450 shares in the company, valued at $2,767,284. The disclosure for this sale can be found here. 0.24% of the stock is owned by corporate insiders.

INC Research Holdings Company Profile

INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.

Insider Buying and Selling by Quarter for INC Research Holdings (NASDAQ:INCR)

Receive News & Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.